Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
A Kaiser Permanente randomized controlled trial comparing an in-person diabetes prevention program with an online version found both helped San Francisco City and County employees at risk for developing diabetes to lose weight.
Pregnant women with overweight or obesity better controlled their weight gain and improved health behaviors when they received a series of telephone sessions with a registered dietician, a new study from Kaiser Permanente finds.
New findings from Kaiser Permanente Division of Research SWIFT Study in PLOS Medicine advance a potential blood test to predict which women with gestational diabetes will go on to develop type 2 diabetes.
Patients with diabetes who used the Kaiser Permanente patient portal and mobile phone app improved their diabetes management outcomes, according to an analysis published Feb. 19 in JAMA Network Open.
Diabetes, medication safety, and understanding chronic conditions are just some of the research areas a new class of postdoctoral fellows at the Kaiser Permanente Northern California Division of Research will support. The 3 early-career researchers began their appointments this past year.
Asian-Americans from different parts of Asia have very different cardiovascular risk factors and chronic conditions such as diabetes, hypertension, and heart disease, Kaiser Permanente research concludes.
Monique Hedderson is heading a five-year project to test whether a mobile phone app could help overweight and obese women avoid excess weight gain, and the accompanying health risks, while pregnant.
Kaiser Permanente investigator Andrew Karter and colleagues will receive $3.2 million over 5 years from the National Institute on Aging to study what older patients with diabetes want from their treatment.
Listen on KP RESEARCH RADIO:
“What we learned is that contrary to recommendations from leading societies, sicker patients were more likely to be on insulin, and over time were less likely to be discontinued from their insulin.”
- Dr. Richard Grant, senior author of study in JAMA Internal Medicine.
Kaiser Permanente research finds members of U.S. ethnic and racial minority groups have diabetes at lower body mass index than white patients.